Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Three compounds from Dadap leaves may help treat hair loss.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Aging causes skin stem cells to work less effectively.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Ruxolitinib treatment may cause eyelash growth.